Comparison of activated charcoal and sodium polystyrene sulfonate resin efficiency on reduction of amitriptyline oral absorption in rat as treatments for overdose and toxicities

Document Type : Original Article


1 Department of Pharmaceutics, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran

2 Center for Nanotechnology in Drug Delivery, Shiraz University of Medical Sciences, Shiraz, Iran

3 International Branch, Shiraz University of Medical Sciences, Shiraz, Iran

4 Department of Pharmacology and Toxicology, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran

5 Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

6 Fars Legal Medicine Organization, Shiraz, Iran


Objective(s): Comparative in vivo studies were carried out to determine the adsorption characteristics of amitriptyline (AMT) on activated charcoal (AC) and sodium polystyrene sulfonate (SPS). AC has been long used as gastric decontamination agent for tricyclic antidepressants and SPS has showed to be highly effective on in-vitro drugs adsorption.
Materials and Methods: Sprague-Dawley male rats were divided into six groups. Group I: control, group II: AMT 200 mg/kg as single dose orally, group III and IV: AC 1g/kg as single dose orally 5 and 30 min after AMT administration respectively, and group 5 and 6: SPS 1 g/kg as single dose orally 5 and 30 min after AMT administration, respectively. 60 min after oral administration of AMT (Tmax of AMT determined in rats), Cmax plasma levels were determined by a validated GC-Mass method.
Results: The Cmax values for groups II to IV were determined as 1.1, 0.5, 0.6, 0.1 and 0.3 µg/ml, respectively.
Conclusion: AC and SPS could significantly reduce Cmax of AMT when administrated either 5 or 30 min after AMT overdose (P<0.05). However, SPS showed to be more effective than AC in reducing Cmax when was administrated immediately (5 min) after AMT overdose. The results suggest a more efficient alternative to AC for AMT and probably other TCA overdoses.


1. Barbui C, Hotopf M. Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials. Br J Psychiatry 2001; 178:129-144.
2. Woolf AD, Erdman AR, Nelson LS, Caravati EM, Cobaugh DJ, Booze LL, et al. Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol 2007; 45:203-233.
3. Pimentel L, Trommer L. Cyclic antidepressant overdoses. A review. Emerg Med Clin North Am 1994; 12:533-547.
4. Cd K. Principles of toxicology and treatment of  poisoning. In: Hardman JG LL, Molinoff PB, Ruddon RW, Gilman AG, editor. Goodman and Gilman’s The Pharmacologic Basis of Therapeutics. 9th ed. New York: McGraw-Hill; 1996. p. 63-75.
5. Ellenhorn MJ BD. Gut decontamination. In: Ellenhorn MJ BD, editor. Medical Toxicology: Diagnosis and Treatment of human poisoning. New York: Elsevier; 1988. p. 54-63.
6. Christophersen ABJ HL. Techniques used to prevent gastrointestinal absorption. In: Flomenbaum NE GL, Hoffman RS, Howland MA, Lewin NA, Nelson LS, editor. Goldfrank’s Emergency Toxicology. 8th ed. New York: McGraw Hill; 2006. p. 109-123.
7. Lawrence DT, Bechtel L, Walsh JP, Holstege CD. The evaluation and management of acute poisoning emergencies. Minerva Med 2007; 98:543-568.
8. Megarbane B, Baud F. [Acute poisoning: general management and main causes]. Rev Prat 2006; 56:1603-1613.
9. Groszek B, Pach J. [Methods of poison elimination--controversies and actual views about their use]. Przegl Lek 1999; 56:442-449.
10. Chernin G, Gal-Oz A, Ben-Assa E, Schwartz IF, Weinstein T, Schwartz D, et al. Secondary prevention of hyperkalemia with sodium polystyrene sulfonate in cardiac and kidney patients on renin-angiotensin-aldosterone system inhibition therapy. Clin Cardiol 2012; 35:32-36.
11. Sterns RH, Rojas M, Bernstein P, Chennupati S. Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective? J Am Soc Nephrol 2010; 21:733-735.
12. Watson M, Abbott KC, Yuan CM. Damned if you do, damned if you don't: potassium binding resins in hyperkalemia. Clin J Am Soc Nephrol 2010; 5:1723-1726.
13. Amitriptyline [database on the Internet]. Available from: DB00321.
14. Papaverine [database on the Internet]. Available from:
15. Kudo K, Jitsufuchi N, Imamura T. Selective determination of amitriptyline and nortriptyline in human plasma by HPLC with ultraviolet and particle beam mass spectrometry. J Anal Toxicol 1997; 21:185-189.
16. Baeck SK, Lim MA, Park SY, Lee JS, Lee HS, Koo KS. Blood concentrations of amitriptyline and its metabolite in rats after acute oral administration of amitriptyline. J Anal Toxicol 2000; 24:271-274.
17. Ishida R, Ozaki T, Uchida H, Irikura T. Gas chromatographic--mass spectrometric determination of amitriptyline and its major metabolites in human serum. J Chromatogr 1984; 305:73-82.
18. Position paper: cathartics. J Toxicol Clin Toxicol 2004; 42:243-253.
19. Rademaker CM, van Dijk A, de Vries MH, Kadir F, Glerum JH. A ready-to-use activated charcoal mixture. Adsorption studies in vitro and in dogs: its influence on the intestinal secretion of theophylline in a rat model. Pharm Weekbl Sci 1989; 11:56-60.
20. Hoegberg LC, Groenlykke TB, Abildtrup U, Angelo HR. Combined paracetamol and amitriptyline adsorption to activated charcoal. Clin Toxicol 2010; 48:898-903.
21. Srikanth MV SS, Rao NS, Uhumwangho MU, Ramana Murthy KV. Ion-exchange resins as controlled drug delivery carriers. J. Sci. Res 2010; 2: 599-613.
22. Ghannoum M, Lavergne V, Yue CS, Ayoub P, Perreault MM, Roy L. Successful treatment of lithium toxicity with sodium polystyrene sulfonate: a retrospective cohort study. Clin Toxicol 2010; 48:34-41.
23. Toyoguchi T, Ebihara M, Ojima F, Hosoya J, Nakagawa Y. In vitro study of the adsorption characteristics of drugs. Biol Pharm Bull 2005; 28:841-844.
24. Polystyrene sulfonate[database on the Internet]. Available from: DB01344.
25. Jamshidzadeh A, Vahedi F, Farshad O, Seradj H, Najibi A, Dehghanzadeh G. Amitriptyline, clomipra-mine, and doxepin adsorption onto sodium polystyrene sulfonate. Daru 2014; 22:2008-2231.
26. Mittelstadt SW, Hemenway CL, Spruell RD. Effects of fasting on evaluation of gastrointestinal transit with charcoal meal. J Pharmacol Toxicol Methods 2005; 52:154-158.